Literature DB >> 26825123

Muscle RANK is a key regulator of Ca2+ storage, SERCA activity, and function of fast-twitch skeletal muscles.

Sébastien S Dufresne1, Nicolas A Dumont1, Antoine Boulanger-Piette1, Val A Fajardo2, Daniel Gamu2, Sandrine-Aurélie Kake-Guena3, Rares Ovidiu David1, Patrice Bouchard1, Éliane Lavergne1, Josef M Penninger4, Paul C Pape3, A Russell Tupling2, Jérôme Frenette5.   

Abstract

Receptor-activator of nuclear factor-κB (RANK), its ligand RANKL, and the soluble decoy receptor osteoprotegerin are the key regulators of osteoclast differentiation and bone remodeling. Here we show that RANK is also expressed in fully differentiated myotubes and skeletal muscle. Muscle RANK deletion has inotropic effects in denervated, but not in sham, extensor digitorum longus (EDL) muscles preventing the loss of maximum specific force while promoting muscle atrophy, fatigability, and increased proportion of fast-twitch fibers. In denervated EDL muscles, RANK deletion markedly increased stromal interaction molecule 1 content, a Ca(2+)sensor, and altered activity of the sarco(endo)plasmic reticulum Ca(2+)-ATPase (SERCA) modulating Ca(2+)storage. Muscle RANK deletion had no significant effects on the sham or denervated slow-twitch soleus muscles. These data identify a novel role for RANK as a key regulator of Ca(2+)storage and SERCA activity, ultimately affecting denervated skeletal muscle function.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  receptor-activator of nuclear factor-κB; sarco(endo)plasmic reticulum Ca2+-ATPase

Mesh:

Substances:

Year:  2016        PMID: 26825123      PMCID: PMC4835920          DOI: 10.1152/ajpcell.00285.2015

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  55 in total

Review 1.  Osteoclast differentiation and activation.

Authors:  William J Boyle; W Scott Simonet; David L Lacey
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

2.  Matching of sarcoplasmic reticulum and contractile properties in rat fast- and slow-twitch muscle fibres.

Authors:  Huong H Trinh; Graham D Lamb
Journal:  Clin Exp Pharmacol Physiol       Date:  2006-07       Impact factor: 2.557

Review 3.  TWEAK and TRAF6 regulate skeletal muscle atrophy.

Authors:  Ashok Kumar; Shephali Bhatnagar; Pradyut K Paul
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2012-05       Impact factor: 4.294

4.  Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Authors:  W S Simonet; D L Lacey; C R Dunstan; M Kelley; M S Chang; R Lüthy; H Q Nguyen; S Wooden; L Bennett; T Boone; G Shimamoto; M DeRose; R Elliott; A Colombero; H L Tan; G Trail; J Sullivan; E Davy; N Bucay; L Renshaw-Gegg; T M Hughes; D Hill; W Pattison; P Campbell; S Sander; G Van; J Tarpley; P Derby; R Lee; W J Boyle
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

5.  TRPV-5 mediates a receptor activator of NF-kappaB (RANK) ligand-induced increase in cytosolic Ca2+ in human osteoclasts and down-regulates bone resorption.

Authors:  Estelle Chamoux; Martine Bisson; Marcel Daniel Payet; Sophie Roux
Journal:  J Biol Chem       Date:  2010-06-11       Impact factor: 5.157

6.  Age-related physiological changes and their clinical significance.

Authors:  G R Boss; J E Seegmiller
Journal:  West J Med       Date:  1981-12

7.  Muscle impairment occurs rapidly and precedes inflammatory cell accumulation after mechanical loading.

Authors:  Jérôme Frenette; Matthieu St-Pierre; Claude H Côté; Eleni Mylona; Frank X Pizza
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2002-02       Impact factor: 3.619

8.  RANKL-induced TRPV2 expression regulates osteoclastogenesis via calcium oscillations.

Authors:  Hiroshi Kajiya; Fujio Okamoto; Tetsuomi Nemoto; Keiichiro Kimachi; Kazuko Toh-Goto; Shuji Nakayana; Koji Okabe
Journal:  Cell Calcium       Date:  2010-10-25       Impact factor: 6.817

9.  Contractile properties and sarcoplasmic reticulum calcium content in type I and type II skeletal muscle fibres in active aged humans.

Authors:  C R Lamboley; V L Wyckelsma; T L Dutka; M J McKenna; R M Murphy; G D Lamb
Journal:  J Physiol       Date:  2015-04-17       Impact factor: 5.182

10.  Alteration of RANKL-induced osteoclastogenesis in primary cultured osteoclasts from SERCA2+/- mice.

Authors:  Yu-Mi Yang; Min Seuk Kim; Aran Son; Jeong Hee Hong; Kyung-Ho Kim; Jeong Taeg Seo; Syng-Ill Lee; Dong Min Shin
Journal:  J Bone Miner Res       Date:  2009-10       Impact factor: 6.741

View more
  21 in total

1.  Increase in phospholamban content in mouse skeletal muscle after denervation.

Authors:  Masatoshi Komatsu; Tsutomu Nakada; Hiroyuki Kawagishi; Hiroyuki Kato; Mitsuhiko Yamada
Journal:  J Muscle Res Cell Motil       Date:  2019-02-26       Impact factor: 2.698

2.  RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass.

Authors:  Nicolas Bonnet; Lucie Bourgoin; Emmanuel Biver; Eleni Douni; Serge Ferrari
Journal:  J Clin Invest       Date:  2019-05-23       Impact factor: 14.808

3.  RANKL Blockade Reduces Cachexia and Bone Loss Induced by Non-Metastatic Ovarian Cancer in Mice.

Authors:  Fabrizio Pin; Alexander J Jones; Joshua R Huot; Ashok Narasimhan; Teresa A Zimmers; Lynda F Bonewald; Andrea Bonetto
Journal:  J Bone Miner Res       Date:  2021-12-13       Impact factor: 6.390

Review 4.  Targeting the Muscle-Bone Unit: Filling Two Needs with One Deed in the Treatment of Duchenne Muscular Dystrophy.

Authors:  Antoine Boulanger Piette; Dounia Hamoudi; Laetitia Marcadet; Françoise Morin; Anteneh Argaw; Leanne Ward; Jérôme Frenette
Journal:  Curr Osteoporos Rep       Date:  2018-10       Impact factor: 5.096

Review 5.  Role of myokines and osteokines in cancer cachexia.

Authors:  Fabrizio Pin; Lynda F Bonewald; Andrea Bonetto
Journal:  Exp Biol Med (Maywood)       Date:  2021-04-25

6.  Soluble RANKL exaggerates hindlimb suspension-induced osteopenia but not muscle protein balance.

Authors:  Toni L Speacht; Charles H Lang; Henry J Donahue
Journal:  J Orthop Res       Date:  2020-12-01       Impact factor: 3.102

7.  Bisphosphonate Treatment Ameliorates Chemotherapy-Induced Bone and Muscle Abnormalities in Young Mice.

Authors:  Alyson L Essex; Fabrizio Pin; Joshua R Huot; Lynda F Bonewald; Lilian I Plotkin; Andrea Bonetto
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-19       Impact factor: 5.555

8.  Physiological role of receptor activator nuclear factor-kB (RANK) in denervation-induced muscle atrophy and dysfunction.

Authors:  Sébastien S Dufresne; Antoine Boulanger-Piette; Sabrina Bossé; Jérôme Frenette
Journal:  Receptors Clin Investig       Date:  2016-05-30

9.  Genetic deletion of muscle RANK or selective inhibition of RANKL is not as effective as full-length OPG-fc in mitigating muscular dystrophy.

Authors:  Sébastien S Dufresne; Antoine Boulanger-Piette; Sabrina Bossé; Anteneh Argaw; Dounia Hamoudi; Laetitia Marcadet; Daniel Gamu; Val A Fajardo; Hideo Yagita; Josef M Penninger; A Russell Tupling; Jérôme Frenette
Journal:  Acta Neuropathol Commun       Date:  2018-04-24       Impact factor: 7.801

10.  Restoration of SERCA ATPase prevents oxidative stress-related muscle atrophy and weakness.

Authors:  Rizwan Qaisar; Shylesh Bhaskaran; Rojina Ranjit; Kavithalakshmi Sataranatarajan; Pavithra Premkumar; Kendra Huseman; Holly Van Remmen
Journal:  Redox Biol       Date:  2018-09-27       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.